Do weight-loss drugs really lead to muscle loss?
Do weight-loss drugs really lead to muscle loss?
Credit: Getty Images
Renowned endocrinologist and diabetologist Dr Ambrish Mithal told IndiaToday.in talked about muscle loss after consuming popular weight-loss drugs.
While reducing weight, whether one is on a diet or even with exercise, body fat along with muscle tends to reduce.
Muscle loss
'The body isn't so fine tuned to reduce fat only during weight loss. When you lose weight, you lose both fat and some muscle. To limit that, you need strength training and enough protein,' he explained.
Exercise, especially strength training, is important to prevent muscle loss, a natural part of rapid weight loss, whether it's achieved through medication, dieting, or surgery.
With both Wegovy and Mounjaro now accessible, India finally has two cutting-edge medical options in the fight against obesity.
'These drugs are designed for long-term use. They're filling a big gap in obesity care. But that doesn't mean lifestyle takes a back seat. These drugs work with lifestyle, not instead of it," said Dr. Mithal.
Weight-loss drugs do not replace diet
The current guidelines suggest prescribing drugs like semaglutide or tirzepatide to people with a BMI over 30, or between 27 and 30 if they have conditions like diabetes, high blood pressure, or heart disease.
Guidelines for prescribing
While Wegovy was launched on June 24, Mounjaro as available in the Indian market since March 2025.
Expert have said that the new-age weight-loss drugs are not a magic cure but powerful ally to reducing obesity crisis.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
3 hours ago
- Business Standard
First Fertility PGS Center Limited Launches Indian Lounge to Welcome International Patients from India Seeking Fertility Treatment in Thailand
PNN Bangkok [Thailand], June 28: First Fertility PGS Center Limited ("First Fertility Clinic") has launched a strategic expansion initiative targeting the Indian medical tourism market for fertility treatments. This initiative positions to capitalize on Thailand's rapidly growing fertility tourism sector, which has emerged as a preferred destination for international patients seeking advanced reproductive care because its combination of world-class medical infrastructure, cost-effective treatments, and regulatory framework that permits comprehensive fertility services including the one-year Medical Visa allows for multiple entries and a stay of up to 90 days per visit for medical tourists. First Fertility PGS Center Limited, a NASDAQ-listed healthcare group and one of Thailand's most established and trusted fertility clinics, has officially launched its new Indian Lounge. This dedicated space has been designed to offer comfort, cultural familiarity, and personalized service for Indian patients seeking high-quality fertility care. With over a decade of experience in reproductive medicine, First Fertility PGS Center has helped thousands of couples from around the world achieve their dream of parenthood. This year marks a significant milestone as the clinic expands its services to better serve the Indian market, one of its fastest-growing patient groups. The newly introduced Indian Lounge provides a calm, private space where Indian patients can feel at ease. It also acts as a hub for multilingual assistance, with a dedicated Hindi-speaking team now available to guide patients throughout every step of their fertility journey, from consultation to treatment and follow-up care. "India is a key focus for us in 2025," said Mr. Siu Wing Fung Alfred, the Managing Director. "We recognize the challenges that come with seeking medical treatment abroad, particularly in such a sensitive area as fertility. Our Indian Lounge and Hindi-speaking support staff reflect our deep commitment to ensuring every Indian patient feels understood, respected, and fully supported." To celebrate the 10th anniversary, First Fertility PGS Center Limited ("First Fertility Clinic") is launching exclusive fertility packages tailored specifically for Indian patients for a limited time only. These special offers include customized pricing, priority booking, and full-service support, including travel coordination, accommodation recommendations, cultural considerations, and reduced price, all to make the experience as smooth, convenient, and stress-free as possible. Located in central Bangkok, First Fertility PGS Center is internationally recognized for its high success rates, advanced technology, and holistic, patient-first approach. The clinic specializes in IVF, ICSI, PGS/PGT-A, PESA/TESE, and a wide range of infertility treatments backed by world-class expertise. For more information, please visit . WhatsApp & Mobile Phone: +66 63 269 2833, IG & Tiktok: firstfertilityconsultant Email: center@
News18
4 hours ago
- News18
Indian CEO's ‘Your Heart Isn't A Machine' Post From Hospital Bed Backfires
Harsh Macwan took to Instagram and shared a picture of himself from the hospital bed, which left the internet divided. Recent years have witnessed a significant rise in heart attack cases, particularly among younger adults. Several factors have contributed to this increase, including lifestyle changes, stress, a poor diet, and a lack of exercise. An Indian CEO recently shed light on such health scares, sharing the near-cardiac incident that left him highly concerned. Harsh Macwan, an IIM Ahmedabad alumnus, recently took to Instagram and shared how he recently 'came dangerously close to something" that led him to the hospital in just a few minutes. In what appears to be an attempt to caution fellow users about the health scare associated with today's fast-paced life, it eventually didn't sit well with everyone. Macwan shared his post, which featured a picture of himself in the hospital bed, now going viral for all the wrong reasons. 'It started with a sharp, crushing pressure in my chest. My left arm went numb. I was breathless, sweating, and disoriented. Within minutes, I was rushed to the hospital. What followed were ECGs and constant monitoring. I've always been the type to push through deadlines, fatigue, and stress. But this time, my body said enough," the CEO wrote in the caption. Further in the post, he urged young founders and leaders to prioritise their health over any startup, client, or ambition. 'Your heart isn't a machine. Take that day off. Sleep. Walk. Switch off your phone. Because when your body gives you a final warning, you won't get to reschedule it," he continued. While Macwan expressed that he is currently recovering, his post received warm reactions on the handle. Many of his followers expressed concern, asking him to take care and get proper rest. One wrote, 'Sending good vibes. Take care," while another added, 'Rightly said… Take care and proper rest." 'Feel better soon," another comment read. On the contrary, the post also grabbed the attention of a Reddit user who reshared the picture and took a jibe with, 'Take a pic, I'm going to post about this to help other founders – Heart Attack LinkedIn Survivor." Further in his post, the user described it as a 'haul of fame of craziest posts," asking people to save themselves. Many others also resonated with the remark, as they too joined in to call out the sharing of the picture. One wrote, 'No, no, take another picture—I don't look pathetic enough yet!!" while another added, 'Cannot wait to have a heart attack to post it on LinkedIn! So exciting!!!" 'The weird thing here is a posed hospital selfie. He's not the only guilty one – but unless it's a posed 'I just gave birth and this is our first family photo" then it's odd. Hope the dude is on the mend now," a user continued. Nonetheless, amid the criticism and well-wishes, the CEO's post does draw attention to the need for working professionals to focus on their lifestyle and health concerns.
India Today
4 hours ago
- India Today
Endocrinologist Dr. Ambrish Mithal on the happy side-effects of weight-loss drugs
New-age weight-loss drugs are exploding the pharmaceutical market, offering better results than traditional medicines. Top endocrinologist Dr. Ambrish Mithal deconstructs the many facets, including side-effects, of these GLP-1 drugs in his recently published book The Weight Loss Revolution, in an episode of India Today's said that while the GLP-1 field -- drugs that belong to the class of GLP-1 targeting the same hormone in the body -- is just beginning to explode, there'll be many newer drugs with less and less side effects and easier to most cases have shown muscle loss as a prominent result of using GLP-1 medications like tirzepatide or semaglutide, Dr. Mithal explains that losing muscle is an accompanying factor to weight loss. "In the long run, if you're not following a healthy diet, you will end up with significant muscle loss. And this is not because of the weight-loss drugs. Whenever we lose weight, we also lose muscle. If you lose 10 kg, you've lost 2-3 kg of muscle. Now, if you want to preserve that, you have to ensure adequate protein and fibre in your diet. Along with that, you have to make sure that you're exercising regularly and that exercise should include strength training," Dr. Mithal also shared what many people experience loose skin after taking these medicines. "When you lose weight rapidly, you lose subcutaneous fat. Particularly in older people where skin tends to sag anyway. If you suddenly lose weight, don't hydrate yourself well, not eating the right kind of balanced diet, then you get that little sagging on the face which people have started calling Ozempic face. Before these drugs came into the market, anyone we put on a very strict diet or someone who had bariatric surgery would see similar results," he gastrointestinal side-effects, nausea, and vomiting, Dr. Mithal addressed concerns about thyroid cancer, highlighting that there's no evidence to link the also explained the "happy side-effects" of GLP-1 medications. Besides growing body of evidence suggesting how semaglutide is linked to Alzheimer's disease, Dr. Mithal said that the benefits of the drugs are moving beyond weight loss."The evidence that they might be helping Alzheimer's by helping obesity in the brain may actually be very exciting, and even for cardiac health, Parkinson's disease. Cardiac events are reduced. Fatty liver is reduced. Kidney disease progression is reduced. But the brain effects are particularly fascinating. Sleep apnea has also gone down," he said, adding that the drugs have also helped improve fertility outcomes in women with PCOS (Polycystic Ovary Syndrome).Currently, most GLP-1 drugs are injectable and expensive, limiting their access in India. However, new formulations and more research are on the way. Novo Nordisk's Wegovy and Eli Lilly's Mounjaro, two blockbuster fat-busting medicines, are set to gain ground in India to tackle the diabetes and obesity crisis."Remember, the GLP-1 field is just beginning to explode. There'll be many newer drugs with less and less side effects and easier to use," Dr. Mithal sayssaid.- EndsMust Watch
